Japan Approves Stem-Cell Therapies for Parkinson's & Heart Failure
US News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Japan Approves Groundbreaking Stem-Cell Therapies for Parkinsons and Heart Failure: In a historic move, Japan has greenlit two pioneering stem-cell therapies, marking the worlds first commercial products using induced pluripotent stem cells (iPS cells). These treatments, Amchepry for Parkinsons and ReHeart for severe heart failure, are set to revolutionize patient care by addressing symptoms and potentially slowing disease progression.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/1625f82b5afa231f